Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

XOMA Royalty Corporation - Common Stock (NQ:XOMA)

24.40 +0.55 (+2.31%)
Streaming Delayed Price Updated: 1:15 PM EDT, Jun 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,213
Open 23.99
Bid (Size) 24.24 (1)
Ask (Size) 24.48 (1)
Prev. Close 23.85
Today's Range 23.99 - 24.65
52wk Range 18.35 - 35.00
Shares Outstanding 11,782,723
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
XOMA Royalty Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Via Benzinga
XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million
From XOMA Royalty Corporation; BioInvent
Via GlobeNewswire

Performance

YTD
-6.2%
-6.2%
1 Month
-9.6%
-9.6%
3 Month
+17.7%
+17.7%
6 Month
-12.3%
-12.3%
1 Year
+0.9%
+0.9%

More News

Read More
XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements
From XOMA Royalty Corporation
Via GlobeNewswire
Forecasting The Future: 5 Analyst Projections For XOMA Royalty
Via Benzinga
A Glimpse Into The Expert Outlook On XOMA Royalty Through 4 Analysts
Via Benzinga
Demystifying XOMA: Insights From 5 Analyst Reviews
Via Benzinga
XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference
From XOMA Royalty Corporation
Via GlobeNewswire
XOMA Royalty Completes Sale of Kinnate Pipeline Assets
From XOMA Royalty Corporation
Via GlobeNewswire
XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference
From XOMA Royalty Corporation
Via GlobeNewswire
The Analyst Verdict: XOMA Royalty In The Eyes Of 4 Experts
Via Benzinga
XOMA Royalty Declares Quarterly Preferred Stock Dividends
From XOMA Royalty Corporation
Via GlobeNewswire
XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business Achievements
From XOMA Royalty Corporation
Via GlobeNewswire
XOMA Royalty to Present at Investor Conferences in March
From XOMA Royalty Corporation
Via GlobeNewswire
XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
From XOMA Royalty Corporation
Via GlobeNewswire
XOMA Royalty Declares Quarterly Preferred Stock Dividends
From XOMA Royalty Corporation
Via GlobeNewswire
XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio
From XOMA Corporation
Via GlobeNewswire
XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities
From XOMA Corporation
Via GlobeNewswire
XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience
From XOMA Corporation
Via GlobeNewswire
Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)
From XOMA Corporation
Via GlobeNewswire
XOMA Royalty Declares Quarterly Preferred Stock Dividends
From XOMA Corporation
Via GlobeNewswire
XOMA Royalty to Present at Upcoming Investor Conferences in September
From XOMA Corporation
Via GlobeNewswire
XOMA Stock Earnings: XOMA Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent Activities
From XOMA Corporation
Via GlobeNewswire
FDA Convenes Expert Panel Meeting For Zevra Therapeutics' Arimoclomol, Analyst Optimistic About Approval Despite Small Patient Base
Via Benzinga
Exposures Product Safety
XOMA Declares Quarterly Preferred Stock Dividends
From XOMA Corporation
Via GlobeNewswire

Frequently Asked Questions

Is XOMA Royalty Corporation - Common Stock publicly traded?
Yes, XOMA Royalty Corporation - Common Stock is publicly traded.
What exchange does XOMA Royalty Corporation - Common Stock trade on?
XOMA Royalty Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for XOMA Royalty Corporation - Common Stock?
The ticker symbol for XOMA Royalty Corporation - Common Stock is XOMA on the Nasdaq Stock Market
What is the current price of XOMA Royalty Corporation - Common Stock?
The current price of XOMA Royalty Corporation - Common Stock is 24.40
When was XOMA Royalty Corporation - Common Stock last traded?
The last trade of XOMA Royalty Corporation - Common Stock was at 06/16/25 01:15 PM ET
What is the market capitalization of XOMA Royalty Corporation - Common Stock?
The market capitalization of XOMA Royalty Corporation - Common Stock is 287.50M
How many shares of XOMA Royalty Corporation - Common Stock are outstanding?
XOMA Royalty Corporation - Common Stock has 287M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.